[Lab] SSA sema — Medutest came back 97.4% against a claimed 96.2%
Long-ish post, sorry. tl;dr at the bottom. I have been tracking 2.4mg against triglycerides for 21 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one lab, one…
Sweden here. Waited 5 months on an NHS list, gave up, went private, and the cost was half what I expected but the admin was worse.
Not convinced. The evidence does not support that reading.
[removed by moderator]
pens are overpriced, research vials are research grade, same molecule different price
the 2.4mg dose is not the target, it is just what the pen goes up to
[removed by moderator]
Disagree on that part. 99.0% and 98.9% on the same vial is normal.
[removed by moderator] Disagree on that part.
Yes, exactly this, and it is the bit that took me 66 weeks to accept.
nope, 0.25 counts, it is just not the dose most people stay on
Slight fix: the number was 98.7, not 99.3. Decimal point, but a fairly consequential one.
Slight fix: the number was 98.7, not 99.3.
Adding to this: Ozempic is doing more work than the comment implies.
my eGFR moved before the scale did and i nearly missed it
the quiet is real. the food noise just stops.
What colour is the pen? Wegovy and Ozempic use different formulations.
pens are overpriced, research vials are research grade, same molecule different price
Cosigning. The slow route gets the outcome, the fast route gets you the side effects.
titration speed is food noise plus side effects, period
Ozempic versus Wegovy versus research grade is the wrong argument, they are literally the same molecule
week 44 and i am still not at maintenance, do not rush the ladder
week 44 and i am still not at maintenance, do not rush the ladder
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.